SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-23-119604
Filing Date
2023-11-17
Accepted
2023-11-17 17:15:11
Documents
2
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS III, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2331039d1_sc13g.htm SC 13G 88889
2 EXHIBIT 99.1 tm2331039d1_ex99-1.htm EX-99.1 6252
  Complete submission text file 0001104659-23-119604.txt   96916
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89108 | Film No.: 231419907
SIC: 2836 Biological Products, (No Diagnostic Substances)